Literature DB >> 27681792

Cancer: Tumour-specific ablation of Treg cells induces anticancer response.

Alexandra Flemming.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27681792     DOI： 10.1038/nrd.2016.198

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy.

Authors:  Kazuhide Sato; Noriko Sato; Biying Xu; Yuko Nakamura; Tadanobu Nagaya; Peter L Choyke; Yoshinori Hasegawa; Hisataka Kobayashi
Journal:  Sci Transl Med       Date:  2016-08-17       Impact factor: 17.956
  1 in total
  3 in total

Review 1.  Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.

Authors:  Mariona Cabo; Rienk Offringa; Laurence Zitvogel; Guido Kroemer; Aura Muntasell; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-08-30       Impact factor: 8.110

2.  TGFβ2 is a Prognostic Biomarker for Gastric Cancer and is Associated With Methylation and Immunotherapy Responses.

Authors:  Bangling Han; Tianyi Fang; Yimin Wang; Yongle Zhang; Yingwei Xue
Journal:  Front Genet       Date:  2022-05-10       Impact factor: 4.772

3.  IL-33 Promotes the Development of Colorectal Cancer Through Inducing Tumor-Infiltrating ST2L+ Regulatory T Cells in Mice.

Authors:  Yaxing Zhou; Yong Ji; Honggang Wang; Hai Zhang; Haihua Zhou
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.